Restricting Topical Ocular Chloramphenicol Eye Drop Use in the United States. Did We Overreact?

Topical ocular chloramphenicol eye drops are relatively inexpensive and have broad-spectrum coverage of most gram-positive, gram-negative, and anaerobic bacteria. Worldwide, it is estimated that more than 50% of the world use topical chloramphenicol as a first-line agent in the treatment of conjunctivitis.

Full Story →